the aid library

LIST OPTIONS

Filter

8470

Sort by:

Direction:

Download (28)

View PDF (33)

تأملات إقليمية: تحليل المشاو ا رت الإقليمية غير الرسمية مع الأشخاص المتعايشين مع الأم ا رض غير السارية وحالات الصحة النفسية

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit... more

Download (27)

View PDF (34)

Ситуация в регионах. Анализ результатов неофициальных консультаций с людьми, живущими с неинфекционными заболеваниями и психическими расстройствами

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

Download (230)

View PDF (204)

End-to-end integration of SARS-CoV-2 and influenza sentinel surveillance: revised interim guidance

World Health Organization WHO (2022) C_WHO

his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience... more

Download (177)

View PDF (128)

National Comprehensive Guidelines on HIV Testing Services

Kenya MInistry of Health, Community Development, Elderly and Children (2019) C1

These guidelines provide a framework for effective action to facilitate access to safe and ethical testing services for different population groups. The implementation of the a comprehensive approach, known as HIV Testing Services (HTS) is cardinal as an effective package of services that diminis... more

Download (113)

View PDF (118)

Tuberculosis Research Funding Trends 2005-2020

World Health Organisation (WHO) (2021) C_WHO

Previous advocacy efforts have achieved tangible goals in terms garnering political commitments to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge now is to ensure that these commitments are actually met within a global biomedical research ecosystem that... more

Download (101)

View PDF (144)

‘Asks’ to the private sector in the response to COVID-19

World Health Organization WHO (2020) C_WHO

The 'asks' have been prepared for private businesses to take concrete actions in the COVID19 pandemic.

Download (119)

View PDF (135)

We can remove punitive laws, policies, practices, stigma and discrimination that block effective responses to HIV

UNAIDS (Joint United Nations Programme on HIVAIDS); UNDP; World Health Organization; et al. (2010) C2

Joint Action for Results UNAIDS Outcome Framework: Business Case 2009–2011

Download (154)

View PDF (244)

Living Planet Report 2020 - Bending the curve of biodiversity loss

World Wildlife Fund for Nature WWF (2020) C2

At a time when the world is reeling from the deepest global disruption and health crisis of a lifetime, this year’s Living Planet report provides unequivocal and alarming evidence that nature is unraveling and that our planet is flashing red warning signs of vital natural systems failure. The ... more

Download (94)

View PDF (139)

Pediatric oncology nursing practice in Latin America and the Caribbean

Pan American Health Organisation PAHO (2024) C_WHO

One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence and promote the training of the health workforce, especially pediatric oncology nurses, specialized in nursing care for children and adolescents with cance... more

Download (163)

View PDF (182)

WHO Guideline on use of ferritin concentrations to assess iron status in individuals and populations

World Health Organization WHO (2020) C_WHO

This guideline provides global, evidence-informed recommendations on the use of indicators for assessing a population’s iron status and application of the use of ferritin concentrations for monitoring and evaluating iron interventions.

Download (146)

View PDF (184)

Situation Analysis and Recommendations: Antibiotic Use and Resitance in Mozambique

The Center for Disease Dynamics, Economics & Policy CDDEP (2015) C2

The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate... more

Download (136)

View PDF (164)

Biobehavioural Survey Guidelines

A. Abdul-Quader, M. Berry, T. Bingham; et al. UNAIDS; World Health Organization; fhi360; et al. (2017) C_WHO

Global HIV Strategic Information Working Group For Populations At Risk For HIV

Download (28)

View PDF (30)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (332)

View PDF (930)

Walking in our shoes: Perspectives of pregnant and breastfeeding women living with HIV on access to and retention in care in Malawi, Uganda and Zambia

Global Network of People Living with HIV (GNP+), International Community of Women Living with HIV (ICW) et al. (2017) C1

The study sought to understand the factors that facilitate women to adhere to treatment and return to health facilities for routine care from their own perspective. The researchers focused on Malawi, Uganda and Zambia, early adopters of the global guidance to provide lifelong treatment for pregnant ... more

Download (92)

View PDF (132)

OSCE human dimension commitments and state responses to the COVID-19 pandemic

Organization for Security and Co-operation in Europe OSCE (2020) CC

The COVID-19 pandemic has been a formative experience for all humanity and a health emergency of global proportions, presenting a huge challenge to national leaders, health systems, and citizens. The findings of a new report by the OSCE Office for Democratic Institutions and Human Rights (ODIHR) sho... more

Download (31)

View PDF (41)

区域性思考: 与有非传染性疾病和精神卫生问题的人举办的非正式区域磋商所作分析 2023

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

Download (130)

View PDF (171)

Modelling the impact of HIVDR : the cost of inaction

A. Phillips World Health Organization; UCL (2016) C_WHO

WHO Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan Webinars 12 13 Dec 2016

Download (241)

View PDF (277)

Accelerating access to hepatitis C diagnostics and treatment

World Health Organization WHO (2021) C2

Overcoming barriers in low- and middle-income countries For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha... more

Download (30)

View PDF (42)

Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors 2023

World Health Organization WHO (2023) C_WHO

The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys... more

Download (197)

View PDF (162)

Clinical management of diphtheria: guideline

World Health Organization WHO (2024) C_WHO

WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen... more